Endogenous hormones and risk of breast cancer in postmenopausal women

作者: Susan E. Hankinson

DOI: 10.3233/BD-2006-24102

关键词:

摘要: Multiple lines of evidence support a central role hormones in the etiology breast cancer. In epidemiologic studies, considerable effort has focused on delineating endogenous risk cancer among postmenopausal women. Recently, substantial additional data accrued from prospective studies where are measured study subjects prior to disease diagnosis. this review, linking sex steroids, prolactin and insulin-like growth factors (IGF) with subsequent women is summarized evaluated. Overall, strong positive association between circulating levels both estrogens androgens now been well confirmed; hormone top 20% distribution (versus bottom 20%) have 2- 3-fold higher Accumulating also indicate significant levels, although confirmation needed. contrast, no important link found IGF-I (and its binding protein, IGFBP-3)

参考文章(117)
T. L. M. Pasha, J. E. Tomaszewski, K. T. Montone, C. V. Clevenger, Wan-Ping Chang, Winnie Ngo, Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. American Journal of Pathology. ,vol. 146, pp. 695- 705 ,(1995)
Endogenous Hormones and Breast Cancer Collaborative Group, None, Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. Journal of the National Cancer Institute. ,vol. 94, pp. 606- 616 ,(2002) , 10.1093/JNCI/94.8.606
Nancylee J. Friedlander, Kay-Tee Khaw, Elizabeth Barrett-Connor, Dehydroepiandrosterone sulfate and breast cancer risk. Cancer Research. ,vol. 50, pp. 6571- 6574 ,(1990)
, Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Journal of the National Cancer Institute. ,vol. 95, pp. 1218- 1226 ,(2003) , 10.1093/JNCI/DJG022
A. A. J. van Landeghem, J. H. H. Thijssen, M. Nabuurs, J. Poortman, Endogenous Concentration and Subcellular Distribution of Estrogens in Normal and Malignant Human Breast Tissue Cancer Research. ,vol. 45, pp. 2907- 2912 ,(1985)
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
Paolo Toniolo, Annekatrin Lukanova, The challenge of measuring circulating estradiol at low concentrations Breast Cancer Research. ,vol. 7, pp. 45- 47 ,(2005) , 10.1186/BCR987
Frank Z. Stanczyk, Christopher Longcope, Hugh E. Stephenson, Lilly Chang, Lisa Kahle, Rosetta Miller, Charlene Franz, Rom T. Falk, Joanne F. Dorgan, Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 6, pp. 177- 181 ,(1997)
J A Tangrea, R T Falk, H E Stephenson, W S Campbell, L Kahle, R Miller, C Franz, C Longcope, J F Dorgan, A Schatzkin, Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 5, pp. 533- 539 ,(1996)
Jonas Manjer, Robert Johansson, Göran Berglund, Lars Janzon, Rudolf Kaaks, Åsa Ågren, Per Lenner, Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes & Control. ,vol. 14, pp. 599- 607 ,(2003) , 10.1023/A:1025671317220